Rupintrivir is a promising candidate for treating severe cases of Enterovirus-71 infection

doi:10.3748/wjg.v16.i2.201

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 2

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5940)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-8) series, Tables (1-1) series.

Item

Count

PDF

547

HTML

5068

Figures (1-8)

188

Tables (1-1)

137

Sum=5940

Jan 14, 2010 (publication date) through Jul 16, 2024

Times Cited of This Article

Times Cited (39)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Jan 14, 2010; 16(2): 201-209
Published online Jan 14, 2010. doi: 10.3748/wjg.v16.i2.201

Full Size Figure Download Figure

Figure 7 Sequence variability of EV71 3C protease and its effect on rupintrivir binding (A) Phylogenetic tree of 48 isolates of EV71 in various outbreaks. (B) A colored representation of sequence variation on the surface of 3C protease. Positions with two, three and over three different residues are labeled green, yellow and red, respectively. Residue Ser 128 and Thr 142 were labeled.

Citation: Zhang XN, Song ZG, Jiang T, Shi BS, Hu YW, Yuan ZH. Rupintrivir is a promising candidate for treating severe cases of Enterovirus-71 infection. World J Gastroenterol 2010; 16(2): 201-209
URL: https://www.wjgnet.com/1007-9327/full/v16/i2/201.htm
DOI: https://dx.doi.org/10.3748/wjg.v16.i2.201